ISRCTN32401805已完成未知
An exploratory study to investigate the optimal scheduling of chemotherapy in patients with operable colorectal liver metastases
Southampton University Hospitals NHS Trust (UK)0 个研究点目标入组 78 人开始时间: 2011年9月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 78
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Confirmed colorectal adenocarcinoma
- •2. Presence of potentially resectable colorectal cancer liver metastases without detectable extra-hepatic tumour that cannot be completely resected
- •3. 18 years of age or older
- •4. Fit for chemotherapy and surgery
- •5. Eastern Cooperative Oncology Group (ECOG) performance status = 2
- •6. Adequate hematologic, renal and hepatic function
- •7. No prior chemotherapy for metastatic disease
- •8. Adjuvant chemotherapy may have been given if >6 months previously
- •9. If oxaliplatin has been given as adjuvant, irinotecan may be used
- •10. Rectal chemoradiotherapy must be completed > 1 month before treatment
- •11. Male or female participants
排除标准
- •1. Patients in whom there is an indication for chemotherapy to facilitate a R0 resection
- •2. Patients in whom radio frequency ablation is felt to be an essential component of treatment
- •3. Positive pregnancy test
研究者
相似试验
进行中（未招募）
1 期
EPOC B - An exploratory study to investigate the optimal scheduling of chemotherapy in patients with operable colorectal liver metastases.Colorectal cancer with resectable liver metastasesMedDRA version: 14.0Level: PTClassification code 10061451Term: Colorectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-003052-40-GBSouthampton University Hospital NHS Trust78
尚未招募
不适用
The exploratory study to determine the optimal initial dose of tyrosine kinase inhibitors including combination immunotherapy in individual patients with advanced renal cell carcinomarenal cell carcinomaJPRN-UMIN000040923Department of Urology, Graduate School of Medicine, Yamaguchi University100
终止
2 期
Optimal Timing of BR55 CEUS of the OvariesOvarian CancerNCT04248153Bracco Diagnostics, Inc3
招募中
4 期
A Study for Finding Optimal Indication for Cicrosporine A in Patients with Kawasaki DiseaseJPRN-jRCTs031230101Hamada Hiromichi320
尚未招募
Unknown
Forward-looking observational study to find out the ideal time frame for integration of implants with jaw bones which underwent radiation treatment for head and neck cancer patientsCTRI/2024/02/062855Tata Memorial Centre